A Phase III, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled Safety and Efficacy Study of SPD503 in Children and Adolescents Aged 6-17 With Attention Deficit Hyperactivity Disorder (ADHD)
收藏DataCite Commons2025-01-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008005/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine the efficacy of SPD503 compared to placebo in the
treatment of children and adolescents aged 6-17 with ADHD.
提供机构：
Vivli
创建时间：
2022-06-23
